HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discovery of Novel Isatin-Based p53 Inducers.

Abstract
A series of isatin Schiff base derivatives were identified during in silico screening of the small molecule library for novel activators of p53. The compounds selected based on molecular docking results were further validated by a high-content screening assay using U2OS human osteosarcoma cells with an integrated EGFP-expressing p53-dependent reporter. The hit compounds activated and stabilized p53, as shown by Western blotting, at higher rates than the well-known positive control Nutlin-3. Thus, the p53-activating compounds identified by this approach represent useful molecular probes for various cancer studies.
AuthorsP Davidovich, V Aksenova, V Petrova, D Tentler, D Orlova, S Smirnov, V Gurzhiy, A L Okorokov, A Garabadzhiu, G Melino, N Barlev, V Tribulovich
JournalACS medicinal chemistry letters (ACS Med Chem Lett) Vol. 6 Issue 8 Pg. 856-60 (Aug 13 2015) ISSN: 1948-5875 [Print] United States
PMID26288684 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: